Aaron Calvo
Founder & CEOForage AI, LLC
FounderView Profile →Co-Founder · Wired Informatics
Britt Fitch is a co-founder of Wired Informatics, a 2013 Boston Children's Hospital spinoff that commercialized Harvard-affiliated clinical natural-language-processing research as the Invenio platform. He shared first authorship of the peer-reviewed de-identification paper the company was built on.
Last reviewed: Sep 19, 2026
Co-Founder Wired Informatics
Last Reviewed: September 19, 2026
Britt Fitch is a co-founder of Wired Informatics, a company spun out of Boston Children’s Hospital — a teaching affiliate of Harvard Medical School — in 2013 to turn clinical natural-language-processing research into commercial software. The company’s platform, Invenio, extracts structured knowledge from unstructured clinical narrative for researchers, hospitals and medical-record processors, pairing fine-grained patient-profile data mining with analytics that combine biomarker and clinical data. Fitch’s claim on the work is direct rather than commercial: he shared first authorship of the de-identification paper that made the underlying technique publishable and the spinout possible, and the company’s own leadership page names him as the founding team member responsible for technology.
Fitch’s route into healthcare technology ran through research rather than through a commercial software career. In 2013 he was working at the Harvard Medical School Center for Biomedical Informatics, the affiliation printed under his name in BMC Medical Informatics and Decision Making that October. The paper he co-wrote there addressed a specific obstacle: clinical notes hold the richest detail about patients but are largely unusable for research because they carry protected health information. The method he and Andrew McMurry developed combined public and private medical text to de-identify physician notes more accurately than either source alone allowed.
Wired Informatics was founded the same year to sell that capability. It was structured as a spinoff of Boston Children’s Hospital, and its pitch rested on the credibility of the research team rather than on a funding narrative — the company’s own description of its founding team emphasizes contributions to open-source NLP projects and publication in industry journals. Invenio, the resulting platform, was aimed at hospitals, pharmaceutical customers and analytics buyers who needed to read clinical narrative at scale. Fitch carried the technology remit on a three-person leadership team.
The publicly visible record of the company thins out sharply after its first few years. A March 2015 post described pairing Invenio with Hadoop for large-scale data mining; a November 2015 announcement described the MaxMD partnership. The company’s website has not been updated since — its footer still reads 2015, and no later post exists on its feed. A 2018 Becker’s Health IT speaker-series interview with the company’s strategy lead is the most recent independent sign of operation that this review located. Nothing dated 2019 or later was found in any source consulted, so Fitch’s current involvement, and the company’s current status, are both genuinely unresolved rather than confirmed.
No education record could be established from any primary or independently verifiable source. Degree entries carried by an earlier version of this profile traced only to an aggregator listing and have been removed rather than asserted; see the verification notes, where the removed values are recorded in case a primary source later supports them.